Windtree Therapeutics (WINT) Misses Q1 EPS by 12c

Windtree Therapeutics (NASDAQ: WINT) reported Q1 EPS of ($1.70), $0.12 worse than the analyst estimate of ($1.58). Revenue for the quarter came in at $75 thousand, versus $191 thousand reported last year.

For earnings history and earnings-related data on Windtree Therapeutics (WINT) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• JPMorgan Upgrades Lithium Americas Corp. (LAC:CN) (LAC) to Overweight
• ServiceTitan, Inc. (TTAN) Misses Q2 EPS by 1c, Offers Guidance